Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Feb 11, 2026
•
2 min read
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
Feb 10, 2026
Early clinical data shows the London startup’s tiny, minimally invasive, sensor matches commercial CGM accuracy.
Feb 9, 2026
3 min read
Dexcom's G7 Trends tab offers users more diabetes insights, showcasing time in range, sensor usage, and key metrics, with more insights expected in the future.
Portal Diabetes is developing a fully closed-loop implantable pump that delivers insulin into the intraperitoneal cavity—achieving 4–5× faster insulin action.
Feb 6, 2026
4 min read
Insulet's highly anticipated data platform, Omnipod Discover, is available to healthcare providers and Omnipod users across the Middle East.
Feb 5, 2026
Following a 2025 recall of millions of sensors, the FDA points to gaps in Abbott’s quality verification process, sparking renewed discussion on device reliability.
